Canadian (TSX) Life Sciences Industry Analysis
- 7D2.9%
- 3M-15.8%
- 1Y-10.1%
- YTD-39.1%
Over the last 7 days, the Life Sciences industry has risen 2.9%, driven by gains from ImmunoPrecise Antibodies of 10%. Meanwhile, Rapid Dose Therapeutics actually underperformed within the industry, shrinking 8.3% in the last week. However, the industry is down 10% over the past year.
Industry Valuation and Performance
Has the Canadian Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Wed, 01 Dec 2021 | CA$279.2m | CA$21.0m | -CA$14,997,109.00 | 25.9x |
| Fri, 29 Oct 2021 | CA$252.5m | CA$20.7m | -CA$14,899,797.00 | 25.2x |
| Sun, 26 Sep 2021 | CA$243.2m | CA$20.7m | -CA$11,409,216.00 | 21.1x |
| Tue, 24 Aug 2021 | CA$240.3m | CA$20.7m | -CA$11,409,216.00 | 20.4x |
| Wed, 30 Jun 2021 | CA$217.1m | CA$19.8m | -CA$8,728,216.00 | 22.5x |
| Sat, 03 Apr 2021 | CA$240.0m | CA$18.6m | -CA$3,008,537.00 | 27.5x |
| Tue, 05 Jan 2021 | CA$335.5m | CA$17.9m | -CA$2,477,523.00 | 70.2x |
| Fri, 09 Oct 2020 | CA$233.3m | CA$16.1m | -CA$3,428,320.00 | 169x |
| Thu, 02 Jul 2020 | CA$124.3m | CA$15.0m | -CA$4,969,536.00 | n/a |
| Sun, 05 Apr 2020 | CA$51.0m | CA$12.6m | -CA$7,843,897.00 | n/a |
| Wed, 08 Jan 2020 | CA$72.2m | CA$12.2m | -CA$25,037,278.00 | n/a |
| Tue, 01 Oct 2019 | CA$91.7m | CA$12.7m | -CA$23,070,665.00 | 92.3x |
| Fri, 05 Jul 2019 | CA$105.9m | CA$11.9m | -CA$21,794,476.00 | n/a |
| Mon, 08 Apr 2019 | CA$108.0m | CA$10.9m | -CA$17,437,548.00 | n/a |
| Thu, 10 Jan 2019 | CA$118.9m | CA$10.0m | -CA$9,158,301.00 | n/a |
n/a
Current Industry PE: There is only one profitable company in this industry, so there is insufficient data to make an industry-wide assessment of PE.
Past Earnings Growth: The earnings for companies in the Life Sciences industry have deteriorated over the last three years, while revenues for these companies have grown 28% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Canadian Life Sciences industry?
| Clinical Research and Equipment | 2.86% | |
Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry even though it's trading below its 3-year average PE ratio of 70.2x. This is likely because analysts are expecting annual earnings growth of 2.2% and investors are willing to pay a premium for that growth.
Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 2.2% over the next 5 years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | 7D | 1Y | Valuation | |
|---|---|---|---|---|
| IPA ImmunoPrecise Antibodies | 12.3%+CA$16.1m | -24.4% | PS7.8x |